Health Care/Hospital

AiRISTA Receives Frost & Sullivan's 2026 North American Competitive Strategy Leadership Recognition for Healthcare Real-Time Location Solutions

The company's interoperable RTLS platform, customer-centric strategy, and continuous innovation are transforming healthcare asset management and operational efficiency. SAN ANTONIO, July 30, 2026 /PRNewswire/ -- Frost & Sullivan

2026-07-30 22:00 2141

HKEY-AI2Vivo™ 1.0: HKeyBio Accelerates In Vivo Translation for AI-Designed Candidates

HKEY-AI2Vivo™ 1.0 supports the move from computational hypotheses to in vivo translational evidence in autoimmune and allergy research BOSTON and SUZHOU, China, July 30, 2026 /PRNewswire/ -- HKeyBio has establishedHKEY-AI2Vivo™ 1.0, its AI Candidate In Vivo Validation Acceleration Program. The p...

2026-07-30 21:06 2480

Insilico Medicine Launches the Industry's First Drug Discovery and Development (DDD) Benchmark as a Service, to Evaluate Frontier AI and Foundation Models on Real-World Science

Leveraging 30+ validated PCC programs and over 12 years of model development experience to create a large-scale real-world "blind test" for frontier AI and foundation models, with a transparent public leaderboard. CAMBRIDGE, Mass., July 30, 2026 /PRNewswire/ -- As general-purpose and domain-spec...

2026-07-30 21:00 3192

NIPRO CORPORATION Receives FDA 510(k) Clearance for ELISIO™-HX, Introducing HDs to the United States

New medium-cutoff Dialyzer with a Super High-flux membrane brings NIPRO's approach to expanded hemodialysis to United States healthcare providers.  OSAKA, Japan, July 30, 2026 /PRNewswire/ -- NIPRO CORPORATION has been granted 510(k) clearance for the ELISIO-HX dialyzer by the United States Food ...

2026-07-30 20:10 2403

Continuity Biosciences Appoints Vicky Papoutsis to Board of Directors

Business development and corporate strategy executive joins Board as Company advances its clinical programs and partnering activity BRADENTON, Fla., July 30, 2026 /PRNewswire/ -- Continuity Biosciences today announced the appointment of Vicky Papoutsis to its Board of Directors. Vicky brings mor...

2026-07-30 20:00 1731

Ping An Group Upgrades Longevity Management Service System, Unveils 11 Health Longevity Centers Nationwide

SHANGHAI, July 30, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An Group") held a service upgrade press conference yesterday themed "Professionalism Safeguards a Century of Wellbeing", officially upgrading its "Ping An Health Longevity Management Service System". ...

2026-07-30 18:19 2481

NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC

CHENGDU, China, July 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application of its trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) sacituzumab tirumotecan...

2026-07-30 17:19 2726

As the Silver Economy Embraces AI: China's Elderly Care Innovation Competition Reveals Three Trends

SHANGHAI, July 30, 2026 /PRNewswire/ -- In Shanghai, China's city with the deepest aging population, a national competition focused on silver economy innovation has just concluded. The AID Silver Economy Creativity, Innovation and Entrepreneurship Competition, held by Shanghai Aging Industry Deve...

2026-07-30 16:46 2126

AIA Singapore expands cross-border medical access and digitalised care for more than 1 million employees

 With over one-third (34%) of Singapore residents concerned over the affordability of healthcare services[1] and medical inflation projected to reach a record-high of 16.9%[2], AIA Singapore aims to bridge these cost and accessibility gaps with its upcoming corporate policy enhancements – all at ...

2026-07-30 11:00 6656

Propel Health Australia Highlights Emerging Research into Fulvic Acid and Microplastics

BRISBANE, Australia, July 30, 2026 /PRNewswire/ -- Propel Health is highlighting new laboratory research published in Science of the Total Environment showing that fulvic acid can interact directly with microplastic particles under controlled conditions.

2026-07-30 08:01 1906

Piramal Pharma Limited Announces Results for Q1 FY27

MUMBAI, India, July 29, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30th June 2026.   Consolidated Financial Hig...

2026-07-30 03:38 2504

Ractigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms

Funding led by Guozhong Capital will accelerate Phase 2 development for saRNA candidate RAG-01 and CNS asset RAG-17, advance systemic saRNA program RAG-18 toward IND, and expand extrahepatic RNA delivery technologies. NANTONG, China, July 29, 2026 /PRNewswire/ -- Ractigen Therapeutics, a clinica...

2026-07-29 21:57 3462

Insilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma

* FDA Fast Track Designation (FTD) aims to accelerate the review process of high-value assets, and ISM6331 marks Insilico's first FTD, recognizing the clinical potential in advanced m...

2026-07-29 20:30 3217

Fosun International Issues Positive Profit Alert: Profit Attributable to Owners of the Parent for 1H2026 Expected to be Approx. RMB 1.5 Billion to RMB1.8 Billion

HONG KONG, July 29, 2026 /PRNewswire/ -- On 29th July, Fosun International (00656.HK) issued a positive profit alert. Its profit attributable to owners of the parent for the first half of 2026 is expected to range from approximately RMB1.5 billion to RMB1.8 billion representing an increase of app...

2026-07-29 17:35 4342

Ping An Ranks 48th on 2026 Fortune Global 500 List, Marking 17th Consecutive Year on List

HONG KONG and SHANGHAI, July 29, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group"; HKEX: 2318; SSE: 601318) ranked No. 48 on the 2026 Fortune Global 500 list, released on July 28. The list ranks the world's largest corporations by reve...

2026-07-29 15:37 4517

Wellness Culture Gains Momentum Across Asia Pacific as 4 in 5 Consumers Prioritize Holistic Health - Herbalife Survey

HONG KONG, July 29, 2026 /PRNewswire/ -- Herbalife, a premier health and wellness company, community and platform, released findings from its latest survey, revealing a clear rise in a wellness culture - the modern phenomenon that emphasizes the active pursuit of holistic well-being through the ...

2026-07-29 11:00 7214

AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer

* ELAHERE is the first and only antibody-drug conjugate (ADC) therapy approved specifically for patients with folate receptor alpha (FRα) positive, platinum-resistant high grade serous epithelial ovarian cancer, fallopian tube or primary peritoneal cancer, who have received one to three prior s...

2026-07-29 10:00 2769

Australian medtech Navi raises $A6.8 million to commercialise breakthrough paediatric technology in the US

MELBOURNE, Australia and BOSTON, July 29, 2026 /PRNewswire/ -- Melbourne- and Boston-based medical device company Navi Medical Technologies has closed a $A6.8 million capital raise to commercialise its breakthrough paediatric vascular access technology in the United States.

2026-07-29 08:00 2391

Ozelle Launches O-Cyte 1 at ADLM 2026, Marking a New Step in AI-Powered Hematology

The global launch brings image-based morphology intelligence into routine hematology workflows through AI × CBM technology. FRANKFURT, Germany and ANAHEIM, Calif., July 29, 2026 /PRNewswire/ -- Ozelle has officially launched O-Cyte 1, its newest automated hematology a...

2026-07-29 05:00 2007

Torrey Pines Medicine Secures Angel Round to Advance Next-Generation Ultra-Long-Acting Peptide Therapeutics

Led by Lotus Lake Capital, the financing will accelerate the development of TPM004, a differentiated ultra-long-acting amylin/calcitonin receptor dual agonist, and advance the company's proprietary PepTetris™ peptide discovery platform for obesity, diabetes, and other metabolic diseases * Deve...

2026-07-28 20:00 1972
1 ... 29303132333435 ... 846

Week's Top Stories